ScFvs are generated from the heavy and light chain Fv sequences (target binding regions) of antibodies that bind to various therapeutic targets, and STANDs are generated by fusing stabilizer peptide tags. DNA and mRNA encoding STAND are introduced into target cells by various drug delivery systems such as adeno-associated virus vectors, lipid nanoparticles (LNP), and mRNA.